Neal Walker - 09 Aug 2024 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Matthew Rothman, Attorney-in-Fact
Issuer symbol
ACRS
Transactions as of
09 Aug 2024
Net transactions value
+$31,355
Form type
4
Filing time
13 Aug 2024, 16:15:05 UTC
Previous filing
05 Aug 2024
Next filing
04 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Options Exercise $31,355 +43,548 +3.3% $0.7200 1,356,153 09 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACRS Employee Stock Option (right to buy) Options Exercise $0 -43,548 -100% $0.000000* 0 09 Aug 2024 Common Stock 43,548 $0.7200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.